HealthChampion Appoints Jordan Dolin to Board of Directors
Share Article
Thirty-year, three-time startup veteran joins leadership team.
Jordan Dolin, an intrepid entrepreneur with more than 30 years of experience as a founder and operator, has been named to the Board of Directors of HealthChampion, a digital health analytics company. Jordan has a lengthy track record of supporting and championing entrepreneurs and has been an active member of Chicago’s startup community for his entire career. He will be a huge asset to HealthChampion as we navigate new growth opportunities. -HealthChampion’s CEO Terrence M. Ryan CHICAGO (PRWEB) February 11, 2021 HealthChampion, a digital health analytics company and creator of the world’s first consumer-driven health platform, today announced the appointment of Jordan Dolin, an intrepid entrepreneur with more than 30 years of experience as a founder and operator. He ha
This Viewpoint characterizes correctional health care as a separate health system in the US responsible for the lives of 2 million citizens, but largely neglect
The Unique Mental Stressors of COVID-19 s Second Wave medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Right now the COVID-19 vaccine conversation is focused on the fretful disconnect between supply and demand. People who want it can’t get it. Appointments are made and then canceled. Frustration simmers.
That’s today’s reality. There will come a time, educated observers say, when the scenario flips and the rollout, after finally hitting a nice cruising speed, will run into a residual wall of vaccine hesitancy and resistance, the Heartbreak Hill at mile 20 of this marathon.
“Political leaders and public health experts need to recognize that what appears to be considerable public demand for the COVID-19 vaccine right now may be more modest in the coming months,” professors Matt Motta and Timothy Callaghan predict. “In its place, experts will be faced with the new challenge of convincing hesitant groups to get vaccinated in order to reach herd immunity… Developing these communications and identifying appropriate messengers to deliver this information will be vital to stop